|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/16 | |
| A61K 31/4745 | |||
| A61P 17/00 | |||
| A61P 17/02 | |||
| A61P 17/06 | |||
| A61P 17/10 | |||
| A61P 17/12 | |||
| A61K 38/01 | |||
| A61K 8/49 | |||
| A61K 8/64 | |||
| A61Q 19/06 | |||
| A61Q 19/00 | |||
| A61K 31/437 |
| (11) | Patento numeris | 2928485 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13801588.8 |
| Europos patento paraiškos padavimo data | 2013-12-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/075848 |
| Data | 2013-12-06 |
| (87) | Numeris | WO 2014/086994 |
| Data | 2014-06-12 |
| (30) | Numeris | Data | Šalis |
| 201261734428 P | 2012-12-07 | US |
| (72) |
SEIFARTH, Federico G., DE
LAX, Julia, DE
|
| (73) |
Alfa Biogene International B.V.,
Industrie Strasse 9, 48455 Bad Bentheim,
DE
|
| (54) | HSP FOR USE IN TREATMENT FOR IMIQUIMOD RELATED SIDE EFFECTS |
| HSP FOR USE IN TREATMENT FOR IMIQUIMOD RELATED SIDE EFFECTS |